Data / Federal grants / HT942526TERPCTA
DoW Toxic Exposures Clinical Trial Award
Defense Health Agency Contracting Activity - DHACA (Department of Defense) is accepting applications until November 19, 2026. It lists 1 award expected, $4.5 million in total.
SpecStream is the live web data engine for teams and agents. It reads every open and forecast federal opportunity on Grants.gov each morning, and this page is that reading. Describe your organization once and the grants that fit arrive in your sheet, CRM, Slack or agent as they are posted.
Key facts
- Opportunity number
- HT942526TERPCTA
- Status
- Posted, open
- Posted
- May 21, 2026
- Closes
- November 19, 2026
- Expected awards
- 1
- Total funding
- $4,500,000
- Cost sharing
- Not required
- Funding instrument
- Grant
- Category
- Science and Technology and other Research and Development
- Assistance listing
- 12.420 Military Medical Research and Development
- Contact
- Ebony S Simmons Grantor · [email protected] · 301-619-2105
Who can apply
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
What the agency says
Summary: The fiscal year 2026 (FY26) Toxic Exposures Research Program (TERP) Clinical Trial Award (CTA) mechanism supports the advancement, execution, and analysis of clinical trials with the potential to have a significant impact on the prevention, treatment, or management of symptoms, diseases or conditions associated with or resulting from military-related toxic exposures. Proposed projects may range from small proof-of-concept clinical trials (e.g., pilot, first-in-human, phase 0) designed to demonstrate the feasibility or inform the design of more advanced trials, through large-scale trials (including pragmatic clinical trials) to determine efficacy in relevant patient populations.
Distinctive Features: To encourage applications that include meaningful and productive collaborations, the FY26 TERP CTA includes a Partnering Principal Investigator Option (PPIO) . One Principal Investigator (PI) is identified as the initiating PI, and an additional PI may be identified as a Partnering PI. If recommended for funding, each PI will be named on separate awards. The intent is to support interdisciplinary partnerships, such as those between clinicians and research scientists, that will accelerate the movement of promising interventions/knowledge products into clinical applications. Partnering should significantly advance the research beyond what would be possible through independent efforts.
https://cdmrp.health.mil/pubs/press/2026/terppreann
Other open grants from the Department of Defense
| Opportunity | Status | Closes | Award ceiling | Total funding | Record |
|---|---|---|---|---|---|
| ONR FY27 NOFO for Young Investigator Program N0001426SF004 | Open | Oct 30 | grants.gov | ||
| DoW Bone Marrow Failure, Idea Development Award HT942526BMFRPIDA | Open | Nov 4 | $4,000,000 | grants.gov | |
| DoW Bone Marrow Failure, Investigator-Initiated Research Award HT942526BMFRPIIRA | Open | Nov 4 | $1,250,000 | grants.gov | |
| DoW Bone Marrow Failure, Resource Development Award HT942526BMFRPRDA | Open | Nov 4 | $1,250,000 | grants.gov | |
| DoW Reconstructive Transplant, Concept Award HT942526RTRPCA | Open | Nov 4 | $600,000 | grants.gov | |
| DoW Reconstructive Transplant, Investigator-Initiated Research Award HT942526RTRPIIRA | Open | Nov 4 | $8,000,000 | grants.gov |
All grants open to Anyone (unrestricted) · Everything closing in November 2026
Read from the Grants.gov API, last updated 2026-10-23. The agency's notice on Grants.gov is the official record; check it before you apply.